This briefing note is for policymakers and provides key messages on the impact of COVID-19 on people living with NCDs, along with supporting evidence. It is based on recent data as of April 2020, whilst recognising that the evidence base is still rapidly developing. It provides four key messages: people living with NCDs are at a higher risk of severe complications and death from COVID-19; people with compromised immune systems (e.g. due to cancer treatment, diabetes, COPD, steroid treatment) are at high risk of developing complications from COVID-19; evidence indicates that COVID-19 and its treatments may also cause life-threatening or long-lasting impacts; and COVID-19 is disrupting the provision of essential public health functions and necessary health services, including for people living with NCDs. 

Please see NCD's Alliance's resource page for updates.